BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 33560800)

  • 1. Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab.
    Newsom M; Hrin ML; Hamid RN; Strowd LC; Ahn C; Jorizzo JL; Feldman SR
    Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560800
    [No Abstract]   [Full Text] [Related]  

  • 2. Dupilumab, Atopic Dermatitis, and Mycosis Fungoides-New Insights on an Evolving Story.
    Guitart J
    JAMA Dermatol; 2023 Nov; 159(11):1177-1178. PubMed ID: 37851433
    [No Abstract]   [Full Text] [Related]  

  • 3. Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis.
    Boesjes CM; van der Gang LF; Bakker DS; Ten Cate TA; Spekhorst LS; de Graaf M; van Dijk MR; de Bruin-Weller MS
    JAMA Dermatol; 2023 Nov; 159(11):1240-1247. PubMed ID: 37851456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology-based classifier to distinguish early mycosis fungoides from atopic dermatitis.
    Roenneberg S; Braun SA; Garzorz-Stark N; Stark SP; Muresan AM; Schmidle P; Biedermann T; Guenova E; Eyerich K
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2284-2292. PubMed ID: 37422709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitis.
    Murphy MJ; Hwang E; Singh K; Lee T; Cohen JM; Damsky W
    Br J Dermatol; 2023 Dec; 190(1):132-134. PubMed ID: 37818837
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience.
    Simonetti O; Radi G; Diotallevi F; Molinelli E; Rizzetto G; Offidani A
    Clin Exp Dermatol; 2021 Jul; 46(5):939-940. PubMed ID: 33576497
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of facial redness in atopic dermatitis occurring during dupilumab treatment successfully treated with topical delgocitinib ointment.
    Miyagaki T; Okano T; Nakajima K; Mitsuishi S; Kishi A; Miyano K; Takeuchi S; Kadono T
    Dermatol Ther; 2021 Mar; 34(2):e14888. PubMed ID: 33605031
    [No Abstract]   [Full Text] [Related]  

  • 8. Dupilumab treatment of prurigo nodularis in an adolescent.
    Giovannini M; Mori F; Oranges T; Ricci S; Barni S; Canessa C; Liccioli G; Lodi L; Sarti L; Novembre E; Azzari C; Filippeschi C
    Eur J Dermatol; 2021 Feb; 31(1):104-106. PubMed ID: 33586661
    [No Abstract]   [Full Text] [Related]  

  • 9. Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis.
    Bakker DS; van der Wal MM; Heeb LEM; Giovannone B; Asamoah M; Delemarre EM; Drylewicz J; Nierkens S; Boyman O; de Bruin-Weller MS; Thijs JL; van Wijk F
    J Invest Dermatol; 2021 Aug; 141(8):1943-1953.e13. PubMed ID: 33610558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab for severe generalized eczematous eruption complicating common variable immunodeficiency.
    Votquenne N; Dupire G; Michel O; Ben Said B
    Eur J Dermatol; 2021 Feb; 31(1):93-94. PubMed ID: 33586652
    [No Abstract]   [Full Text] [Related]  

  • 11. Alopecia Areata Related Paradoxical Reactions in Patients on Dupilumab Therapy: A Systematic Review.
    Sachdeva M; Witol A; Mufti A; Maliyar K; Yeung J
    J Cutan Med Surg; 2021; 25(4):451-452. PubMed ID: 33586473
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps.
    Hopkins C; Wagenmann M; Bachert C; Desrosiers M; Han JK; Hellings PW; Lee SE; Msihid J; Radwan A; Rowe P; Amin N; Deniz Y; Ortiz B; Mannent LP; Rout R
    Int Forum Allergy Rhinol; 2021 Jul; 11(7):1087-1101. PubMed ID: 33611847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.
    Marcant P; Balayé P; Merhi R; Jendoubi F; Nosbaum A; Raison-Peyron N; Du-Thanh A; Lasek A; Ferrier le Bouedec MC; Tetart F; Valois A; Barbarot S; Soria A; Jachiet M; Staumont-Sallé D;
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e394-e396. PubMed ID: 33594731
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum IgE reduction and paradoxical eosinophilia associated with allergic conjunctivitis after dupilumab therapy.
    Kimura A; Takeda A; Ikebukuro T; Hori J
    J Ophthalmic Inflamm Infect; 2021 Feb; 11(1):3. PubMed ID: 33586015
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerability of and Adherence to Topical Treatments in Atopic Dermatitis: A Narrative Review.
    Tier HL; Balogh EA; Bashyam AM; Fleischer AB; Spergel JM; Masicampo EJ; Kammrath LK; Strowd LC; Feldman SR
    Dermatol Ther (Heidelb); 2021 Apr; 11(2):415-431. PubMed ID: 33599887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting.
    Bavaro N; Gakpo D; Mittal A; Bensko JC; Laidlaw TM; Buchheit KM
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2910-2912.e1. PubMed ID: 33631410
    [No Abstract]   [Full Text] [Related]  

  • 17. Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5).
    Simpson EL; Forman S; Silverberg JI; Zirwas M; Maverakis E; Han G; Guttman-Yassky E; Marnell D; Bissonnette R; Waibel J; Nunes FP; DeLozier AM; Angle R; Gamalo M; Holzwarth K; Goldblum O; Zhong J; Janes J; Papp K
    J Am Acad Dermatol; 2021 Jul; 85(1):62-70. PubMed ID: 33600915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel agents for atopic dermatitis in patients over 50 years of age: A case series.
    Kiely L; Bowe S; O'Connor C; Bennett M; Bourke J; Murphy M
    Dermatol Ther; 2021 Mar; 34(2):e14890. PubMed ID: 33595883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopic Dermatitis: A Patient and Dermatologist's Perspective.
    Berruyer M; Delaunay J
    Dermatol Ther (Heidelb); 2021 Apr; 11(2):347-353. PubMed ID: 33591542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab as promising treatment for prurigo nodularis: current evidences.
    Toffoli L; Farinazzo E; Zelin E; Agozzino M; Dianzani C; Di Meo N; Nan K; Zalaudek I; Conforti C
    J Dermatolog Treat; 2022 May; 33(3):1306-1311. PubMed ID: 33588666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.